← All trials
NCT06543082
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 5, 2024
- Primary completion
- Aug 5, 2027
- Completion date
- Dec 31, 2027
- First posted
- Aug 7, 2024
- Last posted
- Aug 9, 2024
- Enrollment
- 490
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cha Medical UniversityLead sponsor
- Cha Medical UniversityOfficial
- Biotronik, Inc.Collaborator
- Cha Medical UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.